Nuvama’s top 3 Buy recommendation for today are…

Nuvama Institutional Equities has given a Buy rating to select stocks. The recommendations are based on the company’s quarterly results, share price performance and other key metrics like consumer demand, price hikes, and other factors –

Top 3 Buy recommendations by Nuvama 

Bajaj Consumer Care 

The brokerage house retained a Buy rating on Bajaj Consumer Care. However, it slashed the target price by 8.6% to Rs 274 from Rs 300. The brokerage house factored in weak consumer demand and margin pressure. This also led to a cut in earnings per share (EPS) estimates by 9% for FY26 and FY27. The company’s EBITDA was lower in Q3 FY25 which was dented by high copra prices and staff cost. The company’s EBITDA margins came 388 basis points lower YoY to 11.2%. However, the company took a 5% price hike in the quarter to come over the higher copra prices. The management of Bajaj Consumer Care’s EBITDA margin of 11% was an aberration and has guided for 15% in the near term. 

United Breweries

Nuvama Institutional Equities maintained its ‘Buy’ rating on United Breweries. Also, it raised the target price by 5.9% to Rs 2,505 from Rs 2,365. The 15% price hike in Telangana (17% of volume) shall make United Breweries’s state EBITDA neutral versus loss-making earlier. “We like the company’s efforts on continuously investing in growth and affordability along with the announcement of a capex of Rs 750 crore in UP to produce mainstream and premium products, including Heineken, with provision for both cans and bottles,” said Nuvama. However, due to higher-than-expected growth in Premium hurting bottle return rates and a dip in gross margin, the brokerage cut the EPS estimates by 6% for FY26 and FY27. Plus, it took into account the higher interest cost on debt, which the company will take for capital expenditure. 

ALSO READABB jumps nearly 5%: 3 reasons Motilal Oswal maintains ‘Buy’ are… Aditya Birla and Fashion Retail

Nuvama retained its Buy rating on Aditya Birla Fashion and Retail. However, it cut the target price by over 8% to Rs 315 from Rs 343. It maintained the rating as the company’s margins in Q3 FY25 inched up after rolling out lower discounts. Plus, its like-for-like growth in retail channels was in double digits.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth